Abstract: A composition for forming a foamed silicone elastomer is disclosed. The composition comprises: A) an organopolysiloxane having at least two silicon-bonded ethylenically unsaturated groups per molecule; B) an organohydrogensiloxane having at least two silicon-bonded hydrogen atoms per molecule; C) a hydrosilylation catalyst; D) a chemical blowing agent; and E) a physical blowing agent. The hydrosilylation catalyst C) is present in a catalytically effective amount. The chemical blowing agent D) has at least one hydroxyl (OH) group, and is present in an amount to provide a OH content >0 and <500 parts per million (ppm). The physical blowing agent E) undergoes a phase change from a liquid to a gaseous state during exposure to atmospheric pressure and a temperature ?0° C. The blowing agents D) and E) are different from one another. A foamed silicone elastomer, and methods of forming the composition and foamed silicone elastomer are also disclosed.

Abstract: A composition for forming a foamed silicone elastomer is disclosed. The composition comprises: A) an organopolysiloxane having at least two silicon-bonded ethylenically unsaturated groups per molecule; B) an organohydrogensiloxane having at least two silicon-bonded hydrogen atoms per molecule; C) a hydrosilylation catalyst; D) a chemical blowing agent; and E) a physical blowing agent. The hydrosilylation catalyst C) is present in a catalytically effective amount. The chemical blowing agent D) has at least one hydroxyl (OH) group, and is present in an amount to provide a OH content >0 and <500 parts per million (ppm). The physical blowing agent E) undergoes a phase change from a liquid to a gaseous state during exposure to atmospheric pressure and a temperature ?0° C. The blowing agents D) and E) are different from one another. A foamed silicone elastomer, and methods of forming the composition and foamed silicone elastomer are also disclosed.

Abstract: Compounds described herein inhibit biofilm formation or disperse pre-formed biofilms of Gram-negative bacteria. Biofilm-inhibitory compounds can be encapsulated or contained in a polymer matrix for controlled release. Coatings, films, multilayer films, hydrogels, microspheres and nanospheres as well as pharmaceutical compositions and disinfecting compositions containing biofilm-inhibitory compounds are also provided. Methods for inhibiting formation of biofilms or dispersing already formed biofilms are provided. Methods for treating infections of gram-negative bacteria which form biofilms, particularly those of Pseudomonas and more particularly P. aeruginosa.

Abstract: The present invention provides aqueous, epoxy-based sizing compositions for carbon fibers. The size composition incorporates highly functionalized film forming epoxy novolac phenolic resins in combination with highly functionalized sulfonated polyesters having high Tg characteristics, sulfonate equivalent weights in the range from 2000 to 20,000 and number average molecular weights in the range from about 1000 to about 100,000. The present invention also provides corresponding sized carbon fibers and fiber-reinforced matrices.

Abstract: The present invention provides aqueous, epoxy-based sizing compositions for carbon fibers. The size composition incorporates highly functionalized film forming epoxy novolac phenolic resins in combination with highly functionalized sulfonated polyesters having high Tg characteristics, sulfonate equivalent weights in the range from 2000 to 20,000 and number average molecular weights in the range from about 1000 to about 100,000. The present invention also provides corresponding sized carbon fibers and fiber-reinforced matrices.

Abstract: Compounds described herein inhibit biofilm formation or disperse pre-formed biofilms of Gram-negative bacteria. Biofilm-inhibitory compounds can be encapsulated or contained in a polymer matrix for controlled release. Coatings, films, multilayer films, hydrogels, microspheres and nanospheres as well as pharmaceutical compositions and disinfecting compositions containing biofilm-inhibitory compounds are also provided. Methods for inhibiting formation of biofilms or dispersing already formed biofilms are provided. Methods for treating infections of gram-negative bacteria which form biofilms, particularly those of Pseudomonas and more particularly P. aeruginosa.